Literature DB >> 27302555

Mutation Update for Kabuki Syndrome Genes KMT2D and KDM6A and Further Delineation of X-Linked Kabuki Syndrome Subtype 2.

Nina Bögershausen1, Vincent Gatinois2,3,4, Vera Riehmer5, Hülya Kayserili6, Jutta Becker5, Michaela Thoenes5, Pelin Özlem Simsek-Kiper7, Mouna Barat-Houari2,4, Nursel H Elcioglu8, Dagmar Wieczorek9, Sigrid Tinschert10,11, Guillaume Sarrabay2,3,4, Tim M Strom12,13, Aurélie Fabre2, Gareth Baynam14,15,16,17, Elodie Sanchez4, Gudrun Nürnberg18, Umut Altunoglu19, Yline Capri20, Bertrand Isidor21, Didier Lacombe22, Carole Corsini3,4,23, Valérie Cormier-Daire24,25, Damien Sanlaville26, Fabienne Giuliano27, Kim-Hanh Le Quan Sang24, Honorine Kayirangwa24, Peter Nürnberg18, Thomas Meitinger12,13, Koray Boduroglu7, Barbara Zoll1, Stanislas Lyonnet24,25, Andreas Tzschach10, Alain Verloes20, Nataliya Di Donato10, Isabelle Touitou2,3,4, Christian Netzer5, Yun Li1, David Geneviève3,4,23, Gökhan Yigit1, Bernd Wollnik1.   

Abstract

Kabuki syndrome (KS) is a rare but recognizable condition that consists of a characteristic face, short stature, various organ malformations, and a variable degree of intellectual disability. Mutations in KMT2D have been identified as the main cause for KS, whereas mutations in KDM6A are a much less frequent cause. Here, we report a mutation screening in a case series of 347 unpublished patients, in which we identified 12 novel KDM6A mutations (KS type 2) and 208 mutations in KMT2D (KS type 1), 132 of them novel. Two of the KDM6A mutations were maternally inherited and nine were shown to be de novo. We give an up-to-date overview of all published mutations for the two KS genes and point out possible mutation hot spots and strategies for molecular genetic testing. We also report the clinical details for 11 patients with KS type 2, summarize the published clinical information, specifically with a focus on the less well-defined X-linked KS type 2, and comment on phenotype-genotype correlations as well as sex-specific phenotypic differences. Finally, we also discuss a possible role of KDM6A in Kabuki-like Turner syndrome and report a mutation screening of KDM6C (UTY) in male KS patients.
© 2016 WILEY PERIODICALS, INC.

Entities:  

Keywords:  KDM6A; KDM6C; KMT2D; Kabuki syndrome; MLL2; UTY

Mesh:

Substances:

Year:  2016        PMID: 27302555     DOI: 10.1002/humu.23026

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  45 in total

1.  Diagnostic Utility of Genome-wide DNA Methylation Testing in Genetically Unsolved Individuals with Suspected Hereditary Conditions.

Authors:  Erfan Aref-Eshghi; Eric G Bend; Samantha Colaiacovo; Michelle Caudle; Rana Chakrabarti; Melanie Napier; Lauren Brick; Lauren Brady; Deanna Alexis Carere; Michael A Levy; Jennifer Kerkhof; Alan Stuart; Maha Saleh; Arthur L Beaudet; Chumei Li; Maryia Kozenko; Natalya Karp; Chitra Prasad; Victoria Mok Siu; Mark A Tarnopolsky; Peter J Ainsworth; Hanxin Lin; David I Rodenhiser; Ian D Krantz; Matthew A Deardorff; Charles E Schwartz; Bekim Sadikovic
Journal:  Am J Hum Genet       Date:  2019-03-28       Impact factor: 11.025

2.  Genomic DNA Methylation Signatures Enable Concurrent Diagnosis and Clinical Genetic Variant Classification in Neurodevelopmental Syndromes.

Authors:  Erfan Aref-Eshghi; David I Rodenhiser; Laila C Schenkel; Hanxin Lin; Cindy Skinner; Peter Ainsworth; Guillaume Paré; Rebecca L Hood; Dennis E Bulman; Kristin D Kernohan; Kym M Boycott; Philippe M Campeau; Charles Schwartz; Bekim Sadikovic
Journal:  Am J Hum Genet       Date:  2018-01-04       Impact factor: 11.025

3.  Patients with a Kabuki syndrome phenotype demonstrate DNA methylation abnormalities.

Authors:  Nara Sobreira; Martha Brucato; Li Zhang; Christine Ladd-Acosta; Chrissie Ongaco; Jane Romm; Kimberly F Doheny; Regina C Mingroni-Netto; Debora Bertola; Chong A Kim; Ana Ba Perez; Maria I Melaragno; David Valle; Vera A Meloni; Hans T Bjornsson
Journal:  Eur J Hum Genet       Date:  2017-11-07       Impact factor: 4.246

4.  The defining DNA methylation signature of Kabuki syndrome enables functional assessment of genetic variants of unknown clinical significance.

Authors:  Erfan Aref-Eshghi; Laila C Schenkel; Hanxin Lin; Cindy Skinner; Peter Ainsworth; Guillaume Paré; David Rodenhiser; Charles Schwartz; Bekim Sadikovic
Journal:  Epigenetics       Date:  2017-11-07       Impact factor: 4.528

Review 5.  Genetic characteristics of patients with congenital hyperinsulinism.

Authors:  Mary Ellen Vajravelu; Diva D De León
Journal:  Curr Opin Pediatr       Date:  2018-08       Impact factor: 2.856

6.  Congenital Hypoglycemia Disorders: New Aspects of Etiology, Diagnosis, Treatment and Outcomes: Highlights of the Proceedings of the Congenital Hypoglycemia Disorders Symposium, Philadelphia April 2016.

Authors:  Diva D De Leon; Charles A Stanley
Journal:  Pediatr Diabetes       Date:  2016-10-18       Impact factor: 4.866

7.  UTX-guided neural crest function underlies craniofacial features of Kabuki syndrome.

Authors:  Karl B Shpargel; Joshua Starmer; Chaochen Wang; Kai Ge; Terry Magnuson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-09       Impact factor: 11.205

Review 8.  Kabuki syndrome: review of the clinical features, diagnosis and epigenetic mechanisms.

Authors:  Yi-Rou Wang; Nai-Xin Xu; Jian Wang; Xiu-Min Wang
Journal:  World J Pediatr       Date:  2019-10-05       Impact factor: 2.764

9.  Phenotypic expansion of KMT2D-related disorder: Beyond Kabuki syndrome.

Authors:  Dustin Baldridge; Rebecca C Spillmann; Daniel J Wegner; Jennifer A Wambach; Frances V White; Kathleen Sisco; Tomi L Toler; Patricia I Dickson; F Sessions Cole; Vandana Shashi; Dorothy K Grange
Journal:  Am J Med Genet A       Date:  2020-02-21       Impact factor: 2.802

10.  Genetic abnormalities in a large cohort of Coffin-Siris syndrome patients.

Authors:  Futoshi Sekiguchi; Yoshinori Tsurusaki; Nobuhiko Okamoto; Keng Wee Teik; Seiji Mizuno; Hiroshi Suzumura; Bertrand Isidor; Winnie Peitee Ong; Muzhirah Haniffa; Susan M White; Mari Matsuo; Kayoko Saito; Shubha Phadke; Tomoki Kosho; Patrick Yap; Manisha Goyal; Lorne A Clarke; Rani Sachdev; George McGillivray; Richard J Leventer; Chirag Patel; Takanori Yamagata; Hitoshi Osaka; Yoshiya Hisaeda; Hirofumi Ohashi; Kenji Shimizu; Keisuke Nagasaki; Junpei Hamada; Sumito Dateki; Takashi Sato; Yasutsugu Chinen; Tomonari Awaya; Takeo Kato; Kougoro Iwanaga; Masahiko Kawai; Takashi Matsuoka; Yoshikazu Shimoji; Tiong Yang Tan; Seema Kapoor; Nerine Gregersen; Massimiliano Rossi; Mathieu Marie-Laure; Lesley McGregor; Kimihiko Oishi; Lakshmi Mehta; Greta Gillies; Paul J Lockhart; Kate Pope; Anju Shukla; Katta Mohan Girisha; Ghada M H Abdel-Salam; David Mowat; David Coman; Ok Hwa Kim; Marie-Pierre Cordier; Kate Gibson; Jeff Milunsky; Jan Liebelt; Helen Cox; Salima El Chehadeh; Annick Toutain; Ken Saida; Hiromi Aoi; Gaku Minase; Naomi Tsuchida; Kazuhiro Iwama; Yuri Uchiyama; Toshifumi Suzuki; Kohei Hamanaka; Yoshiteru Azuma; Atsushi Fujita; Eri Imagawa; Eriko Koshimizu; Atsushi Takata; Satomi Mitsuhashi; Satoko Miyatake; Takeshi Mizuguchi; Noriko Miyake; Naomichi Matsumoto
Journal:  J Hum Genet       Date:  2019-09-17       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.